ONCAlert | Upfront Therapy for mRCC
Videos
Rationale for Combining Acalabrutinib With Bendamustine and Rituximab in MCL
8:58 PM, Fri December 14, 2018
Rationale for Adding Daratumumab to RVd in Multiple Myeloma
10:05 PM, Thu December 13, 2018
Long-Term Follow-Up Results From the MURANO Trial in CLL
7:00 PM, Thu December 13, 2018
A Phase III Trial Evaluating Iomab-B Prior to HCT in Relapsed/Refractory AML
6:55 PM, Thu December 13, 2018
IMpower130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC
5:06 PM, Wed December 12, 2018
Advice to Community Oncologists on Treating Patients With GI Cancers
3:44 PM, Tue December 11, 2018
Rationale for Phase I Study of AMG 330 in Relapsed/Refractory AML
2:30 PM, Mon December 10, 2018
Advice for Treating Patients With Lung Cancer
6:57 PM, Fri December 7, 2018
